Plasma Profile of Exclusively Breastfed Infants

NCT ID: NCT01669655

Last Updated: 2015-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

56 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-06-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To characterize nutrient levels in breastfeeding infants and their mothers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this study are (1) to characterize plasma lutein levels in breastfed infants in an Asian population where lactating mothers have diets habitually high in lutein and (2) investigate how blood lutein levels in breastfed infants vary according to lutein content of the mothers' milk in such a population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Fed Infants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infant is judged to be in good health.
* Infant is a singleton from a full term birth.
* Infant's birth weight was \> 2490 g.
* Infant is between 6 weeks and 16 weeks (42 to 112 days).
* Infant must have been exclusively breastfed at enrollment.
* Mother's intake indicates a consumption of an average of at least three servings of fruit and/or vegetables per day.
* Mother is a non-smoker.
* Mother is in good health.
* Mother confirms her intention to continue breastfeeding.

Exclusion Criteria

* An adverse maternal, fetal or infant medical history that is thought to have potential for effects on growth, and/or development.
* Infants who have consumed medications or herbal preparations during past 14 days prior to enrollment.
* Infants who have consumed any solid or liquid foods or juices prior to enrollment.
* Infants who have received any supplements containing carotenoids prior to enrollment.
* Mother who is consuming dietary supplements containing carotenoids.
* Participation in another study that has not been approved as a concomitant study.
Minimum Eligible Age

6 Weeks

Maximum Eligible Age

16 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Nutrition

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xianfeng Zhao, MD, PhD

Role: STUDY_CHAIR

Abbott Nutrition, R&D China

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fudan University of Shanghai

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Xu X, Zhao X, Berde Y, Low YL, Kuchan MJ. Milk and Plasma Lutein and Zeaxanthin Concentrations in Chinese Breast-Feeding Mother-Infant Dyads With Healthy Maternal Fruit and Vegetable Intake. J Am Coll Nutr. 2019 Feb;38(2):179-184. doi: 10.1080/07315724.2018.1490934. Epub 2018 Sep 11.

Reference Type DERIVED
PMID: 30204542 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AK99

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.